How Can We Use the Multimodality Prognostic Score?

J Thorac Oncol. 2016 Mar;11(3):e39. doi: 10.1016/j.jtho.2015.10.026.

Authors

Yuki Kataoka¹, Hiraku Tsujimoto², Yasushi Tsujimoto³

Affiliations

¹ Hospital Care Research Unit, Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan. Electronic address: [email protected].
² Hospital Care Research Unit, Department of Nephrology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.
³ Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.

PMID: 26922921
DOI: 10.1016/j.jtho.2015.10.026

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Lung Neoplasms*
Multimodal Imaging*
Prognosis